AAV-NanoLuc® Transduction Inhibition Assay

new-kit-box new-kit-box new-kit-box new-kit-box new-kit-box new-kit-box

Assess Serum Samples for the Presence of Pre-existing Neutralizing Antibodies Against Common AAV Serotypes

  • Identify suitable candidates for AAV-based therapies
  • Screen against serotypes AAV2, AAV8 and AAV9
  • Simple and sensitive workflow

AAV-NanoLuc® Transduction Inhibition Assay

  Catalog No. Product Name   Size Price Qty  
CS3320A14 Early Access AAV2-NanoLuc® Transduction Inhibition Assay, Complete Kit View Specifications 1 each     Consultar Precio
CS3320A15 Early Access AAV2-NanoLuc® Transduction Inhibition Assay, Core Kit View Specifications 1 each     Consultar Precio
CS3320A16 Early Access AAV8-NanoLuc® Transduction Inhibition Assay, Complete Kit View Specifications 1 each     Consultar Precio
CS3320A17 Early Access AAV8-NanoLuc® Transduction Inhibition Assay, Core Kit View Specifications 1 each     Consultar Precio
CS3320A18 Early Access AAV9-NanoLuc® Transduction Inhibition Assay, Complete Kit View Specifications 1 each     Consultar Precio
CS3320A19 Early Access AAV9-NanoLuc® Transduction Inhibition Assay, Core Kit View Specifications 1 each     Consultar Precio

Early Access = This product is available under our Early Access program - Learn More

Catalog (FT) = This product is available under our Catalog (FT) program - Learn More

Overview
Protocols
Specifications
Resources
Related Products

Detect Neutralizing AAV Antibodies: Go From Serum to Solution

Screening serum samples for neutralizing antibodies (NAbs) is crucial in gene therapy development to ensure the therapy's efficacy and safety. NAbs, pre-existing due to natural exposure, can interfere with the delivery of gene therapy by binding to the AAV vector and preventing it from reaching target cells. This interference reduces treatment effectiveness and potentially triggers immune responses, leading to adverse effects. Identifying candidates with high levels of these antibodies enables developers to refine patient selection, optimize dosing strategies, and design alternative approaches, ultimately improving therapeutic outcomes and minimizing risks.

We developed a simple bioluminescent cell-based assay for detecting neutralizing antibodies against AAV in serum samples: AAV-NanoLuc® Transduction Inhibition Assay.

These assays enable consistent measurement of neutralizing antibodies against AAV serotypes 2, 8 and 9 through measurement of a NanoLuc® luciferase reporter gene. This NanoLuc® AAV reporter system has several advantages over existing assays, such as superior sensitivity, short assay time and the inclusion of assay-ready cells.

AAV Transduction Inhibition Assay Principle

Illustration depicting the AAV-NanoLuc® Transduction Inhibition Assay principle.

Principle of the AAV-NanoLuc® Transduction Inhibition Assay. AAV particles of different serotypes were engineered to express NanoLuc® luciferase. In the absence of neutralizing AAV antibodies, viral transduction of the cells leads to expression of the NanoLuc® gene and luminescent signal. Presence of neutralizing antibodies prevents AAV particles from entering cells, and NanoLuc® luciferase is not expressed. Reduction of luminescent signal is proportional to the NAb titer in serum.


AAV-NanoLuc® Transduction Inhibition Assay

Serotype. Serum. Cells. It’s that simple.

Illustration depicting the AAV-NanoLuc® Transduction Inhibition Assay workflow.

AAV-NanoLuc® Transduction Inhibition Assay workflow. Anti-AAV antibodies in serum samples are detected by measuring transduction inhibition of AAV-NanoLuc® viral particles using luminescence. Complete Kits include all of the required reagents in standardized formats and are easily amenable to high-throughput protocols.

Assay Performance Data

Line graph quantifying NAb titer in human serum samples using the AAV2-NanoLuc® Transduction Inhibition Assay.

Quantifying NAb titer in human serum samples using the AAV2-NanoLuc® Transduction Inhibition Assay. Human serum samples from six unique donors were analyzed using the protocol described above (MOI = 10,000; 24-hour incubation). Percent neutralization values with the 4PL curve fits (solid lines). Three replicates per condition (n = 3) with error plotted as standard deviation.

Line graph quantifying NAb titer in human serum samples using the AAV8-NanoLuc® Transduction Inhibition Assay.

Quantifying NAb titer in human serum samples using the AAV8-NanoLuc® Transduction Inhibition Assay. Human serum samples from six unique donors were analyzed using the protocol described above (MOI = 10,000; 24-hour incubation). Percent neutralization values with the 4PL curve fits (solid lines). Three replicates per condition (n = 3) with error plotted as standard deviation.

Line graph quantifying NAb titer in human serum samples using the AAV9-NanoLuc® Transduction Inhibition Assay.

Quantifying NAb titer in human serum samples using the AAV9-NanoLuc® Transduction Inhibition Assay. Human serum samples from six unique donors were analyzed using the protocol described above (MOI = 10,000; 24-hour incubation). Percent neutralization values with the 4PL curve fits (solid lines). Three replicates per condition (n = 3) with error plotted as standard deviation.

Interested in other Promega tools for gene therapy?
Email us

Protocols

No protocols available

Specifications

Catalog Number:

Contenido

Item Part # Presentación

AAV2-NanoLuc® Viral Particles, 100X

CS3320A01 1 × 60μl

HEK293 Cells

CS3320A13 1 × 0.5ml

Low IgG Serum

G711A 1 × 4ml

DMEM with 4.5g/L Glucose, L-Glutamine, Sodium Pyruvate

J236A 1 × 60ml

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Contenido

Item Part # Presentación

AAV2-NanoLuc® Viral Particles, 100X

CS3320A01 1 × 60μl

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Low IgG Serum

G711A 1 × 4ml

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Contenido

Item Part # Presentación

AAV8-NanoLuc® Viral Particles, 100X

CS3320A03 1 × 60μl

HEK293 Cells

CS3320A13 1 × 0.5ml

Low IgG Serum

G711A 1 × 4ml

DMEM with 4.5g/L Glucose, L-Glutamine, Sodium Pyruvate

J236A 1 × 60ml

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Contenido

Item Part # Presentación

AAV8-NanoLuc® Viral Particles, 100X

CS3320A03 1 × 60μl

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Low IgG Serum

G711A 1 × 4ml

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Contenido

Item Part # Presentación

AAV9-NanoLuc® Viral Particles, 100X

CS3320A05 1 × 60μl

HEK293 Cells

CS3320A13 1 × 0.5ml

Low IgG Serum

G711A 1 × 4ml

DMEM with 4.5g/L Glucose, L-Glutamine, Sodium Pyruvate

J236A 1 × 60ml

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Contenido

Item Part # Presentación

AAV9-NanoLuc® Viral Particles, 100X

CS3320A05 1 × 60μl

Bio-Glo-NL™ Luciferase Assay Buffer

J308A 1 × 10ml

Bio-Glo-NL™ Luciferase Assay Substrate

J309A 1 × 200μl

Low IgG Serum

G711A 1 × 4ml

Certificado de Análisis

Search by lot number

Patentes y Exclusiones

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT.


This material may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for

  • (1) research use,
  • (2) discovery, development and monitoring of biologic drugs and vaccines,
  • (3) quality assurance testing of biologic drugs and vaccines, and
  • (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed.

"Commercial use” means any and all uses of this material by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this material for any use. Recipient has no right to modify or otherwise create variations of the virus or nucleotide sequence of the luciferase gene. In addition, recipient must use a Luciferase Assay System purchased from Promega Corporation for all luminescence assays using this material, or contact Promega to obtain a license for use of this material with reagents other than Promega’s.


PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS MATERIAL. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Promega Cell Line Limited Use Label License (LULL)


BY USE OF THIS MATERIAL, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE.


  • 1. Usage and Transfer Restrictions:
    • 1.1. Recipient may use this material for research use only, which includes but is not limited to drug discovery and development, quality assurance testing and product release assays. No transfer, resale or commercial use of this material is allowed without the written consent of Promega Corporation.
    • 1.2. “Commercial use” means any and all uses of this material or derivatives by recipient for monetary or other consideration, including product manufacture, providing a service, information or data to unaffiliated third parties and resale of the material for any use.
  • 2. Modification Restrictions:
    • 2.1. Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT® technology (e.g., HiBiT), HaloTag® technology or genes stably transfected within the cells.
    • 2.2. Recipient shall have no right to genetically engineer or otherwise modify the cell line.
  • 3. Propagation and Storage:
    • 3.1. The recipient may not propagate the cells, unless material is marked as Propagation Model, Cell Bank or Master Cell Bank; then recipient may propagate and store the cells for long-term use.
  • 4. For all determinations of luminescence or other assay-related activity of this material and its derivatives, recipient must either:
    • 4.1. Use the detection systems specified in the protocol or data report and purchased from Promega for all luminescence assays when using this material; or
    • 4.2. Contact Promega to obtain a license for use of this material with reagents other than a Bio-Glo™ branded luciferase reagent, including but not limited to:
      • 4.2.1 Bio-Glo™, Bio-Glo-NL™, Bio-Glo-NB™ TCK, Bio-Glo-NB™ VLP, Bio-Glo-NB™ Lytic
  • 5. For uses of this material for energy transfer (such as bioluminescence resonance energy transfer), recipient must:
    • 5.1. Use NanoBRET™-branded luminescent assay reagents (LARs; e.g., NanoBRET™ Nano-Glo® Substrate), Intracellular TE Nano-Glo® Substrate/Inhibitor or Intracellular TE Nano-Glo® Vivazine™/Inhibitor for all determinations of luminescent activity by this material and its derivatives; and
    • 5.2. Use NanoBRET™-branded energy acceptors (e.g., NanoBRET™ tracers, NanoBRET™ dyes, BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this material and its derivatives; or
    • 5.3. Contact Promega to obtain a license for the use of the material and its derivatives for energy transfer assays to energy acceptors not manufactured by Promega. No license is needed if the energy transfer acceptor is a genetically encoded autofluorescent protein.
  • 6. For uses of HaloTag® Technology in this material, recipient must either:
    • 6.1. Use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties; or
    • 6.2. Contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
  • 7. Disclaimer and Governing Law:
    • 7.1. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE MATERIAL. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Resources

The small size and bright luminescence of NanoLuc® luciferase bring exquisite sensitivity to many applications. From NanoBRET® technology, a BRET-based method to study protein:protein and protein:small molecule interactions, to NanoLuc® Binary Technology (NanoBiT), NanoLuc is the cornerstone for studying genetic responses and protein dynamics in cells at physiologically relevant levels. The flexibility of NanoLuc® technologies provides you with the bioluminescent building blocks to understand biological interactions or perform compound screening in ways that have never been possible before.

Learn about NanoLuc® Luciferase
nanoluc-infographic